Tumor-host interactions play a critical role in tumor growth and progression. An infiltrative growth pattern at the tumor margin observed by pathologic examination is characterized by widespread dissemination of tumor cells into normal tissue structures with loss of a clear boundary between tumor and host tissue. 1 Studies have shown that an infiltrative growth pattern is associated with shorter patient survival in colorectal cancer. [2] [3] [4] [5] [6] [7] [8] [9] [10] However, the true nature of this association remains uncertain. An infiltrating growth pattern is inversely correlated with the presence of immune and inflammatory responses at the invasive tumor front. 1, 4, 5 In fact, greater lymphocytic reaction to colorectal cancer has been associated with longer patient survival. [11] [12] [13] [14] [15] Alternatively, infiltrative growth pattern may reflect specific tumor molecular alterations associated with aggressive tumor behavior. Indeed, studies have shown that infiltrative growth pattern is inversely associated with microsatellite instability (MSI), which has been associated with better patient survival. [16] [17] [18] [19] [20] [21] [22] [23] Because infiltrative growth pattern, lymphocytic reaction, and MSI have all been associated with prognosis, all of these variables can confound each other in survival analysis. To assess a
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prognostic role of tumor growth pattern independent of lymphocytic reaction and tumor molecular features, it is necessary to examine the lymphocytic reaction and tumor molecular features.
We therefore examined the prognostic role of tumor growth pattern, utilizing a database of colorectal cancer patients (n = 1139) in two U.S. nationwide prospective cohort studies. Because patient characteristics and histologic features as well as major tumor molecular features such as MSI, the CpG island methylator phenotype (CIMP), long interspersed nucleotide element 1 (LINE-1) methylation, and KRAS, BRAF, and PIK3CA mutations have been accumulated in our database, we were able to evaluate the effect of tumor growth pattern, independent of these potential confounders.
MATERIALS AND METHODS

Study Population
We utilized the database of two U.S. nationwide prospective cohort studies, the Nurses' Health Study (121,701 women followed since 1976) and the Health Professionals Follow-up Study (51,529 men followed since 1986). 24, 25 Every 2 years, participants were sent follow-up questionnaires to identify newly diagnosed cancer in themselves and their first-degree relatives. When colorectal cancer was identified, study physicians reviewed medical records as well as recorded tumor location and pathologic tumor, node, metastasis stage. We collected paraffin-embedded tissue blocks from hospitals where patients underwent tumor resections. 25 We excluded cases preoperatively treated with radiation and/or chemotherapy. On the basis of the availability of tissue specimens for pathologic analyses, we included a total of 1139 stage I to IV colorectal cancer cases diagnosed up to 2006 (Table 1) . Patients were observed until death or January 1, 2011, whichever came first. Deaths were ascertained by the National Death Index. The cause of death was assigned by physicians unaware of pathologic, molecular, or outcome data. Written informed consent was obtained from all study subjects. This study was approved by the human subjects committees at Brigham and Women's Hospital and the Harvard School of Public Health.
Histopathologic Evaluations
Hematoxylin and eosin-stained tissue sections from all colorectal cancer cases were reviewed by a single study pathologist (S.O.) unaware of other clinical or molecular data, to eliminate the effect of interobserver variability. Tumor differentiation was categorized as well-moderate versus poor ([50% vs. B50% gland formation). The type of tumor growth pattern at the tumor margin was examined at low-power magnification and categorized as expansile, intermediate, or infiltrative (Fig. 1) . Tumor margins were considered expansile when the invasive margin was pushing or reasonably well circumscribed. 3 They were considered intermediate when large to medium-sized glands invaded and the tumor border was not distinct. They were considered infiltrative when small glands or irregular clusters or cords of cells invaded in a diffuse manner with widespread penetration of normal tissues without distinct border. 9 Tumors with a small microscopic focus of an infiltrative growth pattern were considered intermediate. The presence and extent of mucinous and/or signet ring cell component were recorded. Peritumoral lymphocytic reaction was examined as previously described. 13 A subset of cases (n [ 100) were reviewed by a second pathologist (T.M.) and concordance was as follows (all P \ 0.0001): 0.77 (weighted j = 0.62) for tumor growth pattern (trichotomized); 0.96 (j = 0.73) for tumor growth pattern (dichotomized as expansile-intermediate vs. infiltrative); 0.96 (j = 0.72) for tumor differentiation (dichotomized as well-moderate vs. poor); 0.85 (j = 0.70) for presence of mucinous component; 0.93 (j = 0.60) for presence of signet ring cell component; and Spearman r = 0.65 for peritumoral lymphocytic reaction. 13 Because our current study utilized a large sample size, an agreement study on a fraction of cases was a reasonable method to assess the interobserver reproducibility of each histopathologic feature. 4, 10 DNA Extraction, Pyrosequencing of KRAS, BRAF, and PIK3CA, and MSI Analysis DNA was extracted from paraffin-embedded tissue, and we performed PCR and pyrosequencing targeted for KRAS (codons 12 and 13), BRAF (codon 600), and PIK3CA (exons 9 and 20). [26] [27] [28] MSI analysis was performed with 10 microsatellite markers (D2S123, D5S346, D17S250, BAT25, BAT26, BAT40, D18S55, D18S56, D18S67, and D18S487). 29 High MSI was defined as instability in C30% of the markers, and low MSI/microsatellite stability (MSS) as instability in \30% of the markers.
Methylation Analyses for CpG Islands and LINE-1
By means of validated bisulfite DNA treatment and realtime PCR (MethyLight), we quantified DNA methylation in eight CIMP-specific promoters (CACNA1G, CDKN2A, CRABP1, IGF2, MLH1, NEUROG1, RUNX3, and SOCS1). [30] [31] [32] High CIMP was defined as the presence of C6/8 methylated promoters, and low CIMP/0 as 0/8-5/8 methylated promoters, according to previously established criteria. 29 In order to accurately quantify relatively high LINE-1 LINE-1 methylation level, mean ± SD 62.7 ± 9.6 62.7 ± 9.5 62.4 ± 9.7 63.6 ± 9.5 0.44
CIMP CpG island methylator phenotype, MSI microsatellite instability, MSS microsatellite stable, SD standard deviation
Proportion of cases with a specific clinical, pathologic, or molecular feature among each expression group methylation levels, we used pyrosequencing as previously described.
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Statistical Analysis
All statistical analyses were performed by SAS software, version 9.1 (SAS Institute, Cary, NC). All P values were two-sided. For categorical data, the Chi-square test was performed. P values were calculated by analysis of variance for age and LINE-1 methylation level. The Cicchetti-Allison weight was used for calculating the weighted j agreement coefficients for tumor growth pattern (trichotomized variable). Kaplan-Meier method and log rank test were used for survival analyses. For analyses of colorectal cancer-specific mortality, deaths as a result of other causes were censored. To control for confounding, we used multivariate Cox proportional hazard regression models. A multivariate model initially included sex, age at diagnosis (continuous), year of diagnosis (continuous), body mass index (BMI; \30 vs. C30 kg/m 2 ), family history of colorectal cancer in any firstdegree relative (present vs. absent), tumor location (proximal vs. distal), tumor differentiation (well-moderate vs. poor), mucinous component (present or absent), signet ring cells (present or absent), peritumoral lymphocytic reaction (absent/minimal vs. present), MSI (high vs. low/MSS), CIMP (high vs. low/0), LINE-1 methylation (continuous), KRAS, BRAF, and PIK3CA. Disease stage (I, II, III, IV, unknown) was used as a stratifying variable using the ''strata'' option in the SAS ''proc phreg'' command, to minimize residual confounding and overfitting. A backward elimination was performed with P = 0.20 as a threshold to avoid overfitting. For cases with missing information in any of the covariates [BMI (0.2% missing), tumor location (0.5%), peritumoral lymphocytic reaction (0.4%), MSI (8.4%), CIMP (12%), KRAS (7.7%), BRAF (7.9%), and PIK3CA (14%)], we included those cases in a majority category of a given covariate to avoid overfitting. We confirmed that excluding cases with missing information in any of the covariates did not substantially alter results (data not shown). The proportionality of hazard assumption was satisfied by evaluating time-dependent variables, which were the cross-product of the growth pattern variable and survival time (P [ 0.10). An interaction was assessed by the Wald test on the cross product of the growth pattern variable and another variable of interest (without cases missing data) in a multivariate Cox model. To assess an interaction of tumor growth pattern and stage, we dichotomized disease stage (I-III vs. IV).
Additionally, multivariate logistic regression analysis was performed to assess relations with infiltrative tumor growth (as a binary outcome variable 
RESULTS
Tumor Growth Pattern in Colorectal Cancer
Among 1139 colorectal cancers, 372 tumors (33%) exhibited an expansile pattern, 610 tumors (54%) showed an intermediate pattern, and 157 tumors (14%) showed an infiltrative pattern (Fig. 1) . Table 1 shows the relations between tumor growth pattern and various clinical, pathologic and molecular features. Infiltrative growth pattern was associated with advanced stage (P \ 0.0001), and inversely associated with peritumoral lymphocytic reaction (P \ 0.0001) and high MSI (P \ 0.0001).
In multivariate logistic regression analysis, infiltrative growth pattern was inversely associated with high MSI [multivariate OR 0.15; 95% confidence interval (CI), 0.07-0.34; P \ 0.0001] and peritumoral lymphocytic reaction (multivariate OR 0.36; 95% CI, 0.24-0.54; P \ 0.0001), and positively with BRAF mutation (multivariate OR 2.89; 95% CI, 1.68-4.98; P = 0.0001) ( Table 2 ).
Tumor Growth Pattern and Patient Survival in Colorectal Cancer
Among the 1139 patients, there were 528 deaths, including 308 colorectal cancer-specific deaths, during a median follow-up of 137 months (interquartile range, 94-189 months) for those who were censored. In KaplanMeier analysis, infiltrative growth pattern was significantly associated with shorter colorectal cancer-specific and overall survival (both log rank P \ 0.0001) (Fig. 1) .
Infiltrative growth pattern was significantly associated with shorter colorectal cancer-specific and overall survival in univariate Cox regression analysis and in the multivariate Cox model adjusting for clinical, pathologic and molecular features ( 
Stage-specific Analysis of Tumor Growth Pattern and Survival
To evaluate a prognostic effect of tumor growth pattern in each disease stage, we examined stage-specific HR for tumors with infiltrative growth pattern compared with those with expansile or intermediate growth pattern (Table 4 ). The significant prognostic association of infiltrative growth pattern was confined to stage I-III patients. Among stage IV colorectal cancer patients, infiltrative growth pattern was not associated with survival (P interaction with stage = 0.0001 for colorectal cancer-specific survival). The adverse effect of infiltrative growth pattern on (Fig. 2) .
Stratified Analysis of Tumor Growth Pattern and Mortality
We examined whether the prognostic association of tumor growth pattern was modified by any of the other variables including sex, age, year of diagnosis, BMI, family history of colorectal cancer, tumor location, tumor differentiation, mucinous or signet ring cell component, peritumoral lymphocytic reaction, MSI, CIMP, LINE-1 methylation, BRAF, KRAS, and PIK3CA. We did not observe a significant modifying effect by any of the variables (all P interaction [ 0.05). Notably, the effect of tumor growth pattern did not significantly differ between the two cohort studies (P interaction = 0.83).
DISCUSSION
We examined the prognostic significance of tumor growth pattern in a population of stage I to IV colorectal cancer patients who were concurrently assessed for other clinical, pathologic and molecular predictors of patient outcome. Advancing tumor margin is considered to be a tumor area which manifests tumor aggressiveness. 1 We found that an infiltrative growth pattern was associated with worse prognosis among stage I-III colorectal cancer patients, independent of other clinical, pathologic, and molecular characteristics including MSI, CIMP, LINE-1 methylation, and KRAS, BRAF, and PIK3CA mutations. Our results support the role of tumor growth pattern as an independent prognostic factor among stage I-III colorectal cancer patients.
Tumor growth pattern can be assessed at low magnification with ease on routine histopathologic examination of resected colorectal cancer, and an evaluation of this feature can be implemented in clinical practice. Tumor growth pattern has generated considerable interest as an additional prognostic factor. 35 An evaluation of tumor growth pattern has also been integrated into standard practice in Japan. 36 Previous studies as well as the present study demonstrated that tumor growth pattern can be reliably assessed with acceptable levels of intraobserver and/or interobserver agreement. 4, 10, 37 Moreover, assessment is not greatly affected by the site of sampling of the invasive tumor margin. 37 Beyond the previous reports, the present study has shown that this parameter is a reliable prognostic factor independent of tumor molecular variables by multivariate analysis. [2] [3] [4] [5] [6] [7] [8] [9] [10] Examining prognostic and predictive factors is important in cancer research. [38] [39] [40] [41] [42] Infiltrative growth pattern has been associated with shorter survival in colorectal cancer. The multivariate Cox regression model included the same set of covariates selected as in Table 3 However, the mechanism underlying the survival disadvantage associated with infiltrative growth pattern remains speculative. Infiltrative growth pattern may be an indicator of less host immune and inflammatory responses to tumor cells, leading to shorter patient survival. 1, 4, 5, [11] [12] [13] [14] [15] Alternatively, infiltrative growth pattern may reflect specific tumor molecular alterations associated with aggressive tumor behavior. Indeed, studies have shown that infiltrative growth pattern is inversely associated with MSI, which has been associated with better patient survival. [16] [17] [18] [19] [20] [21] [22] [23] Recent studies have further shown that high MSI in colorectal cancer is associated with CIMP, BRAF mutation, and high LINE-1 methylation level, and all of these factors (MSI, CIMP, BRAF mutation and LINE-1 methylation) have been independently related with prognosis of colorectal cancer patients. 29, 33, 34, 43, 44 Therefore, numerous pathologic and molecular features (lymphocytic reactions, MSI, CIMP, BRAF mutation, and LINE-1 methylation) could account for the adverse effect of infiltrative growth pattern. However, none of the previous studies on tumor growth pattern and patient survival has comprehensively examined the aforementioned molecular features in colorectal cancer beyond MSI. In our analysis, the disadvantage associated with infiltrative growth pattern remained statistically significant after adjusting for these various pathologic and molecular features. [2] [3] [4] [5] [6] [7] [8] [9] [10] The frequency of infiltrative growth pattern greatly varies, ranging 17-80% among the previous studies that used the dichotomous classification (i.e. expansile or infiltrative). 6, 45 This fact suggests that there are many cases that may fall into a gray zone between expansile and infiltrative growth patterns. Therefore, to examine the effect of unequivocal infiltrative growth pattern, we used the trichotomous categorization (i.e. expansile, intermediate or infiltrative), which is similar to the Japanese classification. 36 (Table 1) . Thus, the trichotomous categorization (expansile, intermediate or infiltrative) may be a reasonable classification when one evaluates the tumor growth pattern. Interestingly, we found that an infiltrative growth pattern was inversely associated with high MSI, and positively with BRAF mutation in multivariate analysis. Although high MSI is associated with better patient survival, BRAF mutation is associated with worse patient survival. [21] [22] [23] 44, 46, 47 Our results suggest that an infiltrative growth pattern may reflect specific molecular alterations associated with aggressive tumor behavior. Considering that the effects of adjuvant therapy may differ according to tumor molecular features, it may be interesting in future studies to determine the predictive role of tumor growth pattern for response to adjuvant therapies in colorectal cancer because tumor growth pattern can be easily assessed on routine histopathologic examination. [48] [49] [50] There are limitations in this study. For example, data on cancer treatment were limited. Nonetheless, it is unlikely that chemotherapy use substantially differed according to tumor growth pattern because such data were not typically used for treatment decision making. In addition, our multivariate survival analysis finely adjusted for disease stage (I, II, III, IV, unknown), on which treatment decision making was mostly based. As another limitation, beyond cause of mortality, data on cancer recurrences were not available in these cohorts. Nonetheless, colorectal cancerspecific survival is a reasonable surrogate of colorectal cancer-specific outcome.
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There are advantages in using the database of the two independent prospective cohort studies, the Nurses' Health Study and the Health Professionals Follow-up Study, to examine prognostic significance of tumor growth pattern and its interactions with tumoral and host factors. Anthropometric measurements, family history, other clinical information, pathologic and tumor staging data, and tumor molecular features were prospectively collected blinded to patient outcome. Cohort participants who developed cancer were treated at hospitals throughout the United States and thus were more representative of colorectal cancers in the general U.S. population than patients in one to a few academic hospitals. There were no demographic difference between cases with tumor tissue analyzed and those without tumor tissue analyzed. 24 Tumor growth pattern of colorectal cancer was examined by the single pathologist, and a subset of cases were reexamined by a second pathologist for the agreement study. Finally, our rich tumor database enabled us to simultaneously assess pathologic and tumor molecular features and control for confounding by a number of tumor molecular alterations or histologic features. None of the previous studies on tumor growth pattern and patient outcome has examined as many molecular variables as we did in this study.
In summary, our large cohort study suggests that an infiltrative growth pattern is associated with shorter survival of colorectal cancer patients, independent of other clinical, pathologic, and tumor molecular characteristics. Our data suggest a possible role of tumor-stromal interaction as an independent prognostic determinant of behavior of colorectal cancer cells. Future studies are needed to confirm these results as well as to elucidate exact mechanisms by which tumorstromal interaction affects behavior of colorectal cancer.
